PATH UIPATH INC More: the full row for UIPATH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,950,000 shares; 2025Q1: 8,950,000 shares; 2025Q2: 13,722,244 shares; 2025Q3: 16,950,000 shares; 2025Q4: 17,450,000 shares; 2026Q1: 25,207,628 shares; 2026Q2: 30,950,000 shares; 2026Q3: 32,500,000 shares 32,500,000 $417M 55.09% +1,550,000 Timeline KGEI KOLIBRI GLOBAL ENERGY INC More: the full row for KOLIBRI GLOBAL ENERGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,070,568 shares; 2025Q1: 7,070,568 shares; 2025Q2: 7,068,857 shares; 2025Q3: 7,070,568 shares; 2025Q4: 6,934,504 shares; 2026Q1: 6,834,504 shares; 2026Q2: 6,834,504 shares; 2026Q3: 6,834,504 shares 6,834,504 $42.3M 5.58% 0 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 365,369 shares; 2026Q1: 630,161 shares; 2026Q2: 764,256 shares; 2026Q3: 2,436,051 shares 2,436,051 $26.6M 3.51% +1,671,795 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 126,995 shares; 2025Q2: 188,100 shares; 2025Q3: 194,612 shares; 2025Q4: 194,612 shares; 2026Q1: 221,611 shares; 2026Q2: 295,627 shares; 2026Q3: 838,247 shares 838,247 $26.6M 3.51% +542,620 Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 41,764 shares; 2026Q2: 97,173 shares; 2026Q3: 440,930 shares 440,930 $19.7M 2.6% +343,757 Timeline AUTL AUTOLUS THERAPEUTICS LTD More: the full row for AUTOLUS THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,250,000 shares; 2025Q1: 8,600,000 shares; 2025Q2: 9,500,000 shares; 2025Q3: 9,500,000 shares; 2025Q4: 9,500,000 shares; 2026Q1: 9,500,000 shares; 2026Q2: 9,500,000 shares; 2026Q3: 9,500,000 shares 9,500,000 $18.4M 2.43% 0 Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 81,841 shares; 2025Q4: 96,935 shares; 2026Q1: 127,198 shares; 2026Q2: 130,484 shares; 2026Q3: 264,040 shares 264,040 $17.3M 2.28% +133,556 Timeline LYFT LYFT INC More: the full row for LYFT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $15M 1.98% 0 Timeline WK WORKIVA INC More: the full row for WORKIVA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 150,000 shares; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 225,000 shares 225,000 $15M 1.98% -25,000 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 177,840 shares; 2025Q4: 143,327 shares; 2026Q1: 145,480 shares; 2026Q2: 203,543 shares; 2026Q3: 220,647 shares 220,647 $12.9M 1.71% +17,104 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 199,994 shares; 2026Q2: 286,990 shares; 2026Q3: 310,892 shares 310,892 $11.8M 1.56% +23,902 Timeline CXM SPRINKLR INC More: the full row for SPRINKLR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,200,000 shares; 2025Q1: 2,200,000 shares; 2025Q2: 2,200,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: 2,200,000 shares; 2026Q1: 2,200,000 shares; 2026Q2: 2,200,000 shares; 2026Q3: 2,200,000 shares 2,200,000 $10.9M 1.44% 0 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 192,000 shares; 2025Q1: 261,000 shares; 2025Q2: 316,150 shares; 2025Q3: 303,600 shares; 2025Q4: 243,800 shares; 2026Q1: 312,316 shares; 2026Q2: 290,441 shares; 2026Q3: 295,941 shares 295,941 $9.59M 1.27% +5,500 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 131,167 shares; 2025Q2: 147,817 shares; 2025Q3: 188,379 shares; 2025Q4: 166,187 shares; 2026Q1: 218,507 shares; 2026Q2: 255,934 shares; 2026Q3: 275,219 shares 275,219 $9.3M 1.23% +19,285 Timeline HRMY HARMONY BIOSCIENCES HLDGS IN More: the full row for HARMONY BIOSCIENCES HLDGS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 82,824 shares; 2026Q1: 119,340 shares; 2026Q2: 201,036 shares; 2026Q3: 226,677 shares 226,677 $8.9M 1.17% +25,641 Timeline ALKT ALKAMI TECHNOLOGY INC More: the full row for ALKAMI TECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 600,284 shares; 2026Q3: 650,000 shares 650,000 $8.9M 1.17% +49,716 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,632 shares; 2025Q3: 89,612 shares; 2025Q4: 141,172 shares; 2026Q1: 159,791 shares; 2026Q2: 189,979 shares; 2026Q3: 206,778 shares 206,778 $8.38M 1.11% +16,799 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 138,375 shares; 2025Q3: 223,181 shares; 2025Q4: 247,997 shares; 2026Q1: 258,132 shares; 2026Q2: 356,657 shares; 2026Q3: 511,280 shares 511,280 $8.24M 1.09% +154,623 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 619,000 shares; 2025Q2: 699,000 shares; 2025Q3: 223,123 shares; 2025Q4: not reported; 2026Q1: 181,543 shares; 2026Q2: 570,311 shares; 2026Q3: 447,235 shares 447,235 $8.07M 1.07% -123,076 Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 162,018 shares; 2026Q1: 164,839 shares; 2026Q2: 205,579 shares; 2026Q3: 215,529 shares 215,529 $7.17M 0.95% +9,950 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 64,110 shares; 2026Q3: 87,421 shares 87,421 $6.95M 0.92% +23,311 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 47,014 shares 47,014 $6.67M 0.88% new Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,870 shares; 2025Q4: 11,814 shares; 2026Q1: 19,668 shares; 2026Q2: 19,668 shares; 2026Q3: 19,668 shares 19,668 $6.54M 0.86% 0 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 41,250 shares; 2025Q1: 33,806 shares; 2025Q2: 41,531 shares; 2025Q3: 46,456 shares; 2025Q4: 26,934 shares; 2026Q1: 20,059 shares; 2026Q2: not reported; 2026Q3: 35,000 shares 35,000 $6.45M 0.85% new Timeline WBD WARNER BROS DISCOVERY INC More: the full row for WARNER BROS DISCOVERY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 923,725 shares; 2026Q2: 250,000 shares; 2026Q3: 200,000 shares 200,000 $6.19M 0.82% -50,000 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 69,287 shares; 2026Q1: 103,037 shares; 2026Q2: 86,996 shares; 2026Q3: 101,645 shares 101,645 $6.15M 0.81% +14,649 Timeline UBER UBER TECHNOLOGIES INC More: the full row for UBER TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 71,428 shares 71,428 $4.89M 0.65% new Timeline SNOW SNOWFLAKE INC More: the full row for SNOWFLAKE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,000 shares 10,000 $3.4M 0.45% 0 Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 603,424 shares 603,424 $3.21M 0.42% new Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,400,000 shares; 2025Q1: 2,650,000 shares; 2025Q2: 2,810,000 shares; 2025Q3: 2,112,455 shares; 2025Q4: 2,032,455 shares; 2026Q1: 1,292,455 shares; 2026Q2: 1,242,455 shares; 2026Q3: 655,948 shares 655,948 $2.77M 0.37% -586,507 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 56,052 shares; 2026Q3: 56,052 shares 56,052 $669K 0.09% 0 Timeline TECX TECTONIC THERAPEUTIC INC More: the full row for TECTONIC THERAPEUTIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 187,500 shares; 2025Q2: 228,832 shares; 2025Q3: 243,728 shares; 2025Q4: not reported; 2026Q1: 37,588 shares; 2026Q2: 46,516 shares; 2026Q3: 26,798 shares 26,798 $624K 0.08% -19,718 Timeline SLGL SOL-GEL TECHNOLOGIES LTD More: the full row for SOL-GEL TECHNOLOGIES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,307 shares 8,307 $617K 0.08% new Timeline